福建省药品监督管理局GMP符合性检查结果公告(2025年第63号)

Group 1 - The announcement pertains to the compliance inspection results of Lijun Group Fuzhou Fuxing Pharmaceutical Co., Ltd. regarding Good Manufacturing Practice (GMP) [3] - The inspection was conducted based on the Drug Administration Law and relevant regulations, with a focus on the production quality management standards [3] - The inspection covered the production lines for the raw material Vancomycin Hydrochloride, specifically the second and fourth production lines [4] Group 2 - The inspection took place from September 25 to September 27, 2025 [4] - The results indicate that the company’s production practices are compliant with the GMP standards [4] - The inspection was conducted at the company's facility located in Fuzhou, Fujian Province [4]